Cigna Group (CI) operating KPIs
CINYSEHospital & Medical Service PlansFiscal year ends December 31
$298.23−0.18 (-0.06%)
Close on Oct 30, 2026Market cap $78.80BP/E –Yield 2.03%
Cigna pharmaceutical Manufacturer Receivables — Drug Rebates & Discounts Receivable ($M) ($M)
Rebates & administrative fees due from pharmaceutical manufacturers (hidden inside consolidated Accounts Receivable on the GAAP balance sheet).
Latest, FY2025
12,437
Period ended Dec 31, 2025
Change on a year earlier
–
History
5 years
Since FY2018
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Manufacturer Receivables — Drug Rebates & Discounts Receivable ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12,437 | – | SEC Form 10-Q (filed 2026-07-30) ↗ |
| FY2022 | Dec 31, 2022 | 7,108 | – | SEC Form 10-K (filed 2024-02-29) ↗ |
| FY2020 | Dec 31, 2020 | 4,676 | +36.0% | SEC Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 3,439 | +3.6% | SEC Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 3,321 | – | SEC Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Cigna Pharmaceutical Manufacturer Receivables — Drug Rebates & Discounts Receivable ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Cigna SEC filings and investor materials. https://stockdatahq.com/stocks/ci/kpis/pharma_mfg_receivable
See every metric in the Cigna KPI table. Data updated Oct 31, 2026.